<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05102734</url>
  </required_header>
  <id_info>
    <org_study_id>843615</org_study_id>
    <nct_id>NCT05102734</nct_id>
  </id_info>
  <brief_title>Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock: a Phase 0 Trial.</brief_title>
  <official_title>A Phase 0 Trial of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is an open-label, single center, Phase 0 trial that will enroll up to 25&#xD;
      participants with circulatory shock after cardiac surgery. Participants will be administered&#xD;
      a topical sublingual nitroglycerin solution and assessed for changes microcirculatory blood&#xD;
      flow using incident dark field microscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective, open-label trial</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perfused vessel density</measure>
    <time_frame>3-30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Red blood cell velocity</measure>
    <time_frame>3-30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics</measure>
    <time_frame>3-30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Circulatory Shock</condition>
  <condition>Cardiovascular Shock</condition>
  <arm_group>
    <arm_group_label>Topical nitroglycerin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A topical nitroglycerin solution will be applied to the area of interest</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin Topical Product</intervention_name>
    <description>Topical nitroglycerin solution</description>
    <arm_group_label>Topical nitroglycerin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients receiving elective CABG or valvular surgery requiring cardiopulmonary&#xD;
             bypass&#xD;
&#xD;
          -  Receiving postoperative catecholamine therapy to maintain a MAP &gt; 65mmHg, cardiac&#xD;
             index &gt; 2 despite initial fluid resuscitation&#xD;
&#xD;
          -  Invasive hemodynamic monitoring&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Surgical hemorrhage&#xD;
&#xD;
          -  Unable to tolerate sublingual microcirculatory flow imaging&#xD;
&#xD;
          -  Known intolerance or allergy to nitroglycerin&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John C. Greenwood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Greenwood, MD</last_name>
    <phone>800-789-7366</phone>
    <email>john.greenwood@pennmedicine.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital of the University of the Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John C. Greenwood, MD</last_name>
      <phone>800-789-7366</phone>
      <email>john.greenwood@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 21, 2021</study_first_submitted>
  <study_first_submitted_qc>October 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Cardiogenic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Publication of demographics, study drug effects, changes in hemodynamics and microcirculation. Limited, de-identified data can be made available upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

